A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma
Related Posts
Chopard R, Hobohm L, Barco S, Bangalore S, Giri J, Mahfoud F, Moriarty J, Rosenkranz S, Sharp A, Thiele H, Toma C, Tapson VF, Markovitz[...]
Ahmed M, Abbas F, Khan S, Qureshi S, Khan GT, Shafiq SB, Imran W, Waqas SA, Fudim M, Fonarow GC, Greene SJ, Khan MS. Trends[...]
Xu H, Grory BCM, Ikeaba U, Alhanti B, Fonarow GC, Schwamm LH, Smith EE, Messe SR, Ostbye T, De Lemos JA, Peterson ED, Xian Y.[...]